By Humodi A. Saeed , Amina A. Awad.


Pseudomonas aeruginosa ( Ps. aeruginosa ) is a nosocomial pathogen distributed worldwide. The organism is known as the causative agent of many diseases. The aim of this study was to determi ne susceptibility of Ps. aeruginosa to third generation cephalosporins (Ceftazidime, C eftriaxone, Cefotaxime, cefoprazone). Clinical specimens (n= 293 ) were collected from patients in different hospitals, including Khartoum Teaching Hospital, Ea r Nose Throat Hospital, Military Hospital and National Health La boratory. The patients including 55% males and 45% females aging lees than1 to 88 years. Ps. aeruginosa was recovered and identified by conventional metho ds. A total of 68 strains of Ps. aeruginosa were isolated from infected wounds 36 (53%), infected ears 24 (35%), and urine 8 (12%). The study showed that ceftazidime was the most effective (91%) followed by cefoperazone (47%), ceftriaxone (7%) and cefotaxime (3%). The results indicated no significant differences be tween isolates recovered from males or females (P>0.05).


  • Balows, A ; Hausler, W.J ; Herrmann,k.l; Isenberg, H.D and Shadomy, H.J. (1991). Manual of Clinical Microbiology, 5 th edition. Washington DC : American society for Microbiology, pp . 1068 .
  • Barrow, G. I. and Feltham, R. K. A. (2003). Characters of Gram-negative Bacteria. In: Cowan & Steel Manual for Identificati on of Medical Bacteria. Third edition, Cambridge, UK . Ch (6 ) Pp. 130 - 131
  • Bonomo, R.A; Donskkey, C.J; Blumer J.L; Hujer, A.M; Hoyenum , C.K; Jacobs, M.R; Whalen, CC; Salata, R.A (2003). Cefotaxime resistant bacteria colonizing older people admitted to an acute care hospital J. Am. Geriatr Soc Ohio, USA. 51 (4): 519-22
  • Boyd, R. F and Hoerl, B.G (1991). Basic Medical Microbiology. 4 th edition. Little Brown Company, Ch. 1 , pp. 11 -14, Ch. 2 , pp. 265-271.
  • Brooks, G; Butel, J; Morse, S Jawetz, Melnick & Adelb erges (1995). Medical Microbiology. 20 th edition, Librairiw du Liban, Lebanon, Ch. 10, pp. 137-156.
  • Kechrid, A and Ben Hassen (2000). Ps. aeruginosa a multi centric study of antibiotic resistance. Tunis Med. Habib Bourguiba h ospital, Tunis. 82 (12): 1070-4
  • Lee, Y.H ; Hussain, Z.A; Choong , F.P (1990). Comparative susceptibility studies of clinically isolated Ps. aeruginosa , Escherichia coli and Klebsiella spp to cefoperazone and cefotaxime. J Hyg. Epidemiol. Microbiol. Immunol. 34 (3): 299-303
  • Masaad, M (2005). Susceptibility of Ps. aeruginosa to five antimicrobial agents. M.Sc.thesis, Sudan University of Science an d Technology, college of Graduate Studies
  • Qadri, S.M; Billington, O ; and Cunha, B.A (1991). In vitro activity of cefsulodin against multi resistant isolates of Ps. aeruginosa . King Faisal Specialist Hospital, Riyadh, Saudi Arabia, 17 (4): 213-6.
  • Sarver, D.K; Christensen, G.D; Hester, M.G; Ling, F.W; Pate, J.W; Rosenburge, E.W; Anderson, G.D; and Bisno, A.L. (1981). Clinical and laboratory evaluation of cefoperazone.Clin. Ther. 4 (3): 164-74.
  • Tayseer, M.E (1997). The role of environmental aerobic contaminant in post operative wound infection. M.Sc. Thesis Col lege of Graduates, University of Khartoum
  • Watanakunakorn (1983). In vitro activity of ceftriaxone alone or in combination with gentamicin, tobramycin and amikaci n against Ps. aeruginosa , Antimicrobial agent chemotherapy, 24 (2): 305-6.
  • WHO (1997). Manual of antimicrobial resistance and susceptibili ty testing, Division of emergency and other disease su rveillance and control. Antimicrobial resistance program. World Health Organization, Geneva